Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
07-2015 | 04-2015 | 01-2015 | 10-2014 | 07-2014 | |
Operating Expenses | 343 | 374 | 2,055 | 55 | 172 |
Operating Income | -343 | -374 | -2,055 | -55 | -172 |
Other Income | 44 | 0 | -123 | 0 | -7,102 |
Pre-tax Income | -299 | -373 | -2,178 | -55 | -7,274 |
Net Income Continuous | -299 | -373 | -2,178 | -55 | -7,274 |
Net Income | $-299 | $-373 | $-2,178 | $-55 | $-7,274 |
EPS Basic Total Ops | N/A | -2.44 | -10.19 | 0.00 | 76.67 |
EPS Basic Continuous Ops | -1.73 | -1.34 | -11.09 | -0.31 | 76.62 |
EPS Diluted Total Ops | N/A | -2.44 | -10.19 | 0.00 | 76.67 |
EPS Diluted Continuous Ops | -1.73 | -1.34 | -11.09 | -0.31 | 76.62 |
EBITDA(a) | $-343 | $-374 | $-2,055 | $-55 | $-171 |